Table 3 Details of compounds from hydrogen bonds with one or more key active site residues.

From: Herb-target virtual screening and network pharmacology for prediction of molecular mechanism of Danggui Beimu Kushen Wan for prostate cancer

No

Compound full name

Molecular weight

Key active site residues with H-bonds

Binding affinity

R120 (106)

Y355 (341)

Y385 (371)

1. Compounds form hydrogen bonds with three catalytic triad residues

DC012

Azelaic acid

188.22

1

1

1

− 5.6

2. Compounds form hydrogen bonds with two catalytic triad residues

DB019

Senkyunolide F

206.24

1

1

0

− 7.2

DA108

Tetradecanoic acid

228.37

1

1

0

− 6

DA175

5-Acetoxymethylfurfural

168.15

0

1

1

− 5.8

DA164

Trans,trans-2,4-Hexadienyl acetate

140.18

1

1

0

− 5.1

DA114

10-Undecenal

168.28

1

1

0

− 5

ZF04

Tyrosine

181.191

0

1

1

− 4.5

3. Compounds form hydrogen bonds with one catalytic triad residue

DB004

E-Butylidenephthalide

188.22

0

0

1

− 7.4

DB005

Butylphthalide

190.24

0

0

1

− 7.4

DA012

4-Hydroxy-3-butylphthalide

206.24

0

0

1

− 7.4

DB024

3-Butylidenephthalide

188.22

0

0

1

− 7.3

DA053

2,4-Dimethylbenzaldehyde

134.17

0

0

1

− 6.5

DA153

Methyl linolenate

292.5

0

0

1

− 6.3

DA216

P-hydroxyacetophenone

136.15

0

0

1

− 5.9

DA145

E-10-pentadecenol

226.4

1

0

0

− 5.8

DA134

Benzaldehyde

106.12

0

0

1

− 5.3

DA173

2-Nonanone

142.24

0

0

1

− 5.2

DA165

2-Undecanone

170.29

0

0

1

− 5.1

DA196

6-Undecanone

170.29

0

0

1

− 5.1

ZF02

Leucine

131.175

0

0

1

− 4.9

DA172

4-Octanone

128.21

0

0

1

− 4.9